Advertisement
Canada markets open in 6 hours 48 minutes

  • S&P/TSX

    21,871.96
    +64.59 (+0.30%)
     

  • S&P 500

    5,010.60
    +43.37 (+0.87%)
     

  • DOW

    38,239.98
    +253.58 (+0.67%)
     

  • CAD/USD

    0.7298
    -0.0003 (-0.04%)
     

  • CRUDE OIL

    83.02
    +0.17 (+0.21%)
     

  • Bitcoin CAD

    91,187.20
    +398.82 (+0.44%)
     

  • CMC Crypto 200

    1,402.88
    -11.88 (-0.84%)
     

  • GOLD FUTURES

    2,317.40
    -29.00 (-1.24%)
     

  • RUSSELL 2000

    1,967.47
    +19.82 (+1.02%)
     

  • 10-Yr Bond

    4.6230
    +0.0080 (+0.17%)
     

  • NASDAQ futures

    17,324.75
    -25.25 (-0.15%)
     

  • VOLATILITY

    16.94
    -1.77 (-9.46%)
     

  • FTSE

    8,023.87
    +128.02 (+1.62%)
     

  • NIKKEI 225

    37,552.16
    +113.55 (+0.30%)
     

  • CAD/EUR

    0.6854
    +0.0004 (+0.06%)
     

Wall Street Fundamentals Releases New In-Depth Stock Reports on BMY, DD, DOM and LLY

ACCESSWIRE

On Monday, the 10-year Treasury yield spiked to 2.644 percent, the highest in nearly two years. The treasury yield has surged over 1 percent from its intraday low of 1.614 percent on May 1st. There are currently 165 companies (roughly 33 percent) in the S&P 500 Index with dividend yields higher than the 10-year Treasury yield, compared to 257 companies at the end of March. The recent surge in yields has triggered a selloff in dividend paying stocks among investors who flocked to the riskier equities in a low interest-rate environment.

Bristol Myers Squibb Co. (NYSE:BMY - News) shares traded in the range of $45.23 to $46.72 Wednesday before settling to close at $46.47 an increase of 2.86 percent. The stock appears to be facing resistance at the $45.23 and $46.72 levels. The company currently pays a quarterly dividend of $0.35 a share, $1.40 annually, for a dividend yield of roughly 3.0 percent. Shares of Bristol Myers Squibb have fallen approximately 2.0 percent in the past month.

More information on Bristol Myers Squibb and access to the free equity report can be found at:
www.WallStreetFundamentals.com/BMY

E I Du Pont De Nemours And Co. (NYSE:DD - News) shares traded in the range of $52.73 to $53.67 Wednesday before settling to close at $53.53, an increase of 1.23 percent. The stock appears to be facing resistance at the $53.98 and $54.43 levels. The company currently pays a quarterly dividend of $0.45 a share, $1.80 annually, for a dividend yield of roughly 3.4 percent. Shares of Du Pont have fallen approximately 3.3 percent in the past month.

ADVERTISEMENT

More information on Du Pont and access to the free equity report can be found at:
www.WallStreetFundamentals.com/DD

The Dow Chemical Company (NYSE:DOW - News) shares traded in the range of $31.89 to $32.60 Wednesday before settling to close at $32.20. The stock appears to be facing resistance at the $32.70 and $33.01 levels. The company currently pays a quarterly dividend of $0.32 a share, $1.28 annually, for a dividend yield of roughly 4.0 percent. Shares of The Dow Chemical Company have fallen approximately 8.2 percent in the past month.

More information on The Dow Chemical Company and access to the free equity report can be found at:
www.WallStreetFundamentals.com/DOW

Eli Lilly & Co. (NYSE:LLY - News) shares traded in the range of $49.22 to $49.90 Wednesday before settling to close at $49.79, an increase of 1.16 percent. The stock appears to be facing resistance at the $50.89 and $51.51 levels. The company currently pays a quarterly dividend of $0.49 a share, $1.96 annually, for a dividend yield of roughly 3.95 percent. Shares of Eli Lilly have fallen approximately 8.0 percent in the past month.

More information on Eli Lilly and access to the free equity report can be found at:
www.WallStreetFundamentals.com/LLY

Wall Street Fundamentals offers our members a full range of investor services including in-depth equity reports on your favorite companies and timely market updates featuring the hottest stocks trending in the marketplace.

Activate your always free membership by signing up at www.WallStreetFundamentals.com today.

Disclaimer: Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor's reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. Wall Street Fundamentals has no financial relationship with any company whose stock is mentioned in this release.

Contact:
Wall Street Fundamentals
Website: www.WallStreetFundamentals.com
Email: editor@wallstreetfundamentals.com